Hemolytic Disease of the Newborn Caused by Irregular Blood Subgroup (Kell, C, c, E, and e) Incompatibilities: Report of 106 Cases at a Tertiary-Care Centre

Abstract

Objective To determine the clinical spectrum of hemolytic disease due to irregular blood subgroup incompatibility in hospitalized neonates.

Study Design The medical records of the all hospitalized newborn patients diagnosed with indirect hyperbilirubinemia due to subgroup incompatibility in Kell, C, c, E, and e systems were included in the study. Data from 106 newborns with hemolytic jaundice due to irregular blood subgroups were retrospectively evaluated, and clinical and laboratory findings were compared between patients . The treatment modalities given to the patients of each subgroup types and the laboratory findings and treatment modalities of the cases according to Coombs tests results were also analyzed. Fetal affection of the hemolysis and also fetal losses due to irregular red-cell alloimmunization were not detected in prenatal course, as there was no follow-up of these pregnancies.

Results The mean postnatal hospitalizing age was 6.1 ± 5.2 days after birth. The mean total bilirubin level and the mean hemoglobin value on hospitalization were 343.7 ± 63.3 µmol/L (=20.1 ± 3.7 mg/dL) and 14.9 ± 3.4 g/dL, respectively. Of 106 patients identified with irregular subgroup incompatibility, 40 infants (37.7%) were associated with C, 22 (20.8%) with c, 30 (28.3%) with E, 9 (8.5%) with e, and 5 (4.7%) with Kell subgroup system. Positive Coombs tests (either direct and/or indirect) occurred in 28.3% of the study cases. Hydrops fetalis was determined in 5 of 106 neonates (4.7%). Twenty-two of 106 (20.8%) patients required total exchange transfusion. Positive Coombs test in cases required total exchange transfusion was 63.6%.

Conclusion Our data expose the magnitude and spectrum of the potential developing severe hemolytic disease and immune hydrops due to irregular subgroup incompatibility. Minor group antibody screening is recommended both in the mother and the high-risk infants with hyperbilirubinemia and hemolytic disease of the newborn.

Keywords

hyerbilirubinemia - hemolysis - blood subgroup incompatibility - Coombs test - hydrops fetalis - exchange blood transfusion - intravenous immunoglobulin - neonate

• References

• 1 Giblett ER. Blood group antibodies causing hemolytic disease of the newborn. Clin Obstet Gynecol 1964; 10: 1044-1055
• 2 Appelman Z, Lurie S, Juster A, Borenstein R. Severe hemolytic disease of the newborn due to anti-c. Int J Gynaecol Obstet 1990; 33: 73-75
• 3 Bowman JM, Pollock JM, Manning FA, Harman CR, Menticoglou S. Maternal Kell blood group alloimmunization. Obstet Gynecol 1992; 79: 239-244
• 4 Shurin SB. Hematologic problems in the fetus and neonate. In: Avroy AF, Rihard VM, eds. Neonatal Perinatal Medicine. 5th ed. Chicago, IL: Mosby Year Book; 1992
• 5 Gursoy T, Tekinalp G, Yigit S, Korkmaz A, Onderoglu L. Treatment of MN subgroup incompatibility with intravenous immunoglobulin in a newborn. Pediatr Int 2007; 49: 97-99
• 6 Chao AS, Chao A, Ho SY, Chang YL, Lien R. Anti-e alloimmunization: a rare cause of severe fetal hemolytic disease resulting in pregnancy loss. Case Rep Med 2009; 2009: 471623
• 7 Alcock GS, Liley H. Immunoglobulin infusion for isoimmune haemolytic jaundice in neonates. Cochrane Database Syst Rev 2002; 3: CD003313
• 8 Gottstein R, Cooke RWI. Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn. Arch Dis Child Fetal Neonatal Ed 2003; 88: F6-F10
• 9 Girish G, Chawla D, Agarwal R, Paul VK, Deorari AK. Efficacy of two dose regimes of intravenous immunoglobulin in Rh hemolytic disease of newborn—a randomized controlled trial. Indian Pediatr 2008; 45: 649-660
• 10 American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004; 114: 297-316
• 11 Moise KJ. Fetal anemia due to non-Rhesus-D red-cell alloimmunization. Semin Fetal Neonatal Med 2008; 13: 207-214
• 12 Geifman-Holtzman O, Wojtowycz M, Kosmas E, Artal R. Female alloimmunization with antibodies known to cause hemolytic disease. Obstet Gynecol 1997; 89: 272-275
• 13 Koelewijn JM, Vrijkotte TG, van der Schoot CE, Bonsel GJ, de Haas M. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands. Transfusion 2008; 48: 941-952
• 14 Kubo S, Ariga T, Tsuneta H, Ishii T. Can high-dose immunoglobulin therapy be indicated in neonatal rhesus haemolysis? A successful case of haemolytic disease due to rhesus (c.  + E) incompatibility. Eur J Pediatr 1991; 150: 507-508
• 15 Babinszki A, Berkowitz RL. Haemolytic disease of the newborn caused by anti-c, anti-E and anti-Fya antibodies: report of five cases. Prenat Diagn 1999; 19: 533-536
• 16 Barker RN, Gruffydd-Jones TJ, Stokes CR, Elson CJ. Autoimmune haemolysis in the dog: relationship between anaemia and the levels of red blood cell bound immunoglobulins and complement measured by an enzyme-linked antiglobulin test. Vet Immunol Immunopathol 1992; 34: 1-20
• 17 Hachimura K, Uchiyama Y, Ohtani H. [A sensitive enzyme immunoassay for the measurement of small quantities of erythrocyte-associated IgG in patients with systemic lupus erythematosus who had negative direct antiglobulin test]. Nihon Rinsho Meneki Gakkai Kaishi 1999; 22: 63-71
• 18 Bhutani VK, Maisels MJ, Stark AR, Buonocore G ; Expert Committee for Severe Neonatal Hyperbilirubinemia; European Society for Pediatric Research; American Academy of Pediatrics. Management of jaundice and prevention of severe neonatal hyperbilirubinemia in infants. > or =35 weeks gestation. Neonatology 2008; 94: 63-67
• 19 Abrams ME, Meredith KS, Kinnard P, Clark RH. Hydrops fetalis: a retrospective review of cases reported to a large national database and identification of risk factors associated with death. Pediatrics 2007; 120: 84-89
• 20 Singla S, Kumar S, Roy KK, Sharma JB, Kachhawa G. Severe hydrops in the infant of a Rhesus D-positive mother due to anti-c antibodies diagnosed antenatally: a case report. J Med Case Reports 2010; 4: 57-60
• 21 Thakral B, Agrawal SK, Dhawan HK, Saluja K, Dutta S, Marwaha N. First report from India of haemolytic disease of newborn by anti-c and anti-E in Rh (D) positive mothers. Hematology 2007; 12: 377-380